Henry James International Management Inc. Lowers Position in Smith & Nephew plc (NYSE:SNN)

Henry James International Management Inc. trimmed its holdings in shares of Smith & Nephew plc (NYSE:SNN) by 0.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 183,076 shares of the medical equipment provider’s stock after selling 1,507 shares during the period. Smith & Nephew comprises 1.9% of Henry James International Management Inc.’s investment portfolio, making the stock its 15th biggest holding. Henry James International Management Inc.’s holdings in Smith & Nephew were worth $4,994,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. CWM LLC grew its holdings in Smith & Nephew by 68.6% during the fourth quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 388 shares during the period. Allworth Financial LP grew its stake in shares of Smith & Nephew by 1,566.2% during the 3rd quarter. Allworth Financial LP now owns 1,133 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 1,065 shares during the period. GAMMA Investing LLC acquired a new position in shares of Smith & Nephew during the 4th quarter worth $53,000. Signaturefd LLC increased its holdings in shares of Smith & Nephew by 31.3% in the 3rd quarter. Signaturefd LLC now owns 5,322 shares of the medical equipment provider’s stock valued at $132,000 after purchasing an additional 1,268 shares in the last quarter. Finally, Seed Wealth Management Inc. purchased a new stake in Smith & Nephew during the fourth quarter worth about $213,000. 25.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 15th. Three equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Smith & Nephew currently has an average rating of “Moderate Buy”.

Smith & Nephew Stock Performance

Shares of SNN stock traded up $0.34 during mid-day trading on Friday, reaching $24.78. The stock had a trading volume of 1,063,758 shares, compared to its average volume of 1,109,205. The company has a current ratio of 1.77, a quick ratio of 0.72 and a debt-to-equity ratio of 0.44. Smith & Nephew plc has a 12-month low of $21.52 and a 12-month high of $32.71. The business has a 50-day simple moving average of $25.57 and a 200 day simple moving average of $26.01.

Smith & Nephew Announces Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Tuesday, April 2nd will be issued a dividend of $0.462 per share. The ex-dividend date is Monday, April 1st. This represents a yield of 2.8%.

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.